Mar 23, 2021 / NTS GMT
Presentation
Mar 23, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Adele M. Gulfo
Myovant Sciences Ltd. - Interim Chief Commercial Officer & Director
* Bill McMahon
* Dan Rothman
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Hiroyuki Baba
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer of Global Data Design Office
* Myrtle Potter
* Sam Azoulay
* Toru Kimura
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer, Chief Scientific Officer & Director
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division -
Sumitomo Pharma Co Ltd
(OTCPK:DNPUF)
$
4.3
0 (0%)
Market Cap: 1.52 Bil
Enterprise Value: 3.31 Bil
PE Ratio: 0
PB Ratio: 2.04
GF Score: 64/100 Sumitomo Dainippon Pharma Co Ltd Sumitovant Presentation Transcript
Mar 23, 2021 / NTS GMT
Release Date Price:
$18.75
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot